Qian C - Search Results

1

Loss of imprinting and allele switching of p73 in renal cell carcinoma.

Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI, Liu W. Mai M, et al. Among authors: qian c. Oncogene. 1998 Oct 1;17(13):1739-41. doi: 10.1038/sj.onc.1202099. Oncogene. 1998. PMID: 9796703

2

Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.

Wang L, Darling J, Zhang JS, Qian CP, Hartmann L, Conover C, Jenkins R, Smith DI. Wang L, et al. Among authors: qian cp. Oncogene. 1998 Feb 5;16(5):635-42. doi: 10.1038/sj.onc.1201576. Oncogene. 1998. PMID: 9482109

3

Activation of p73 silent allele in lung cancer.

Mai M, Yokomizo A, Qian C, Yang P, Tindall DJ, Smith DI, Liu W. Mai M, et al. Among authors: qian c. Cancer Res. 1998 Jun 1;58(11):2347-9. Cancer Res. 1998. PMID: 9622072

4

Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions.

Mai M, Huang H, Reed C, Qian C, Smith JS, Alderete B, Jenkins R, Smith DI, Liu W. Mai M, et al. Among authors: qian c. Genomics. 1998 Aug 1;51(3):359-63. doi: 10.1006/geno.1998.5387. Genomics. 1998. PMID: 9721206

5

Differential expression and allelotyping of the p73 gene in neuroblastoma.

Liu W, Mai M, Yokomizo A, Qian C, Tindall DJ, Smith DI, Thibodeau SN. Liu W, et al. Among authors: qian c. Int J Oncol. 2000 Jan;16(1):181-5. Int J Oncol. 2000. PMID: 10601564

6

The human p73 promoter: characterization and identification of functional E2F binding sites.

Seelan RS, Irwin M, van der Stoop P, Qian C, Kaelin WG Jr, Liu W. Seelan RS, et al. Among authors: qian c. Neoplasia. 2002 May-Jun;4(3):195-203. doi: 10.1038/sj.neo.7900237. Neoplasia. 2002. PMID: 11988839 Free PMC article.

7

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W. Taniguchi K, et al. Among authors: qian c. Oncogene. 2002 Jul 18;21(31):4863-71. doi: 10.1038/sj.onc.1205591. Oncogene. 2002. PMID: 12101426

8

Mutations in CHEK2 associated with prostate cancer risk.

Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, Qian C, Marks AF, Slager SL, Peterson BJ, Smith DI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu W. Dong X, et al. Among authors: qian c. Am J Hum Genet. 2003 Feb;72(2):270-80. doi: 10.1086/346094. Epub 2003 Jan 17. Am J Hum Genet. 2003. PMID: 12533788 Free PMC article.

9

Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines.

Zheng L, Wang F, Qian C, Neumann RM, Cheville JC, Tindall DJ, Liu W. Zheng L, et al. Among authors: qian c. Hum Mutat. 2006 Oct;27(10):1062-3. doi: 10.1002/humu.9457. Hum Mutat. 2006. PMID: 16941491

10

Identification and chromosomal localization of CTNNAL1, a novel protein homologous to alpha-catenin.

Zhang JS, Nelson M, Wang L, Liu W, Qian CP, Shridhar V, Urrutia R, Smith DI. Zhang JS, et al. Among authors: qian cp. Genomics. 1998 Nov 15;54(1):149-54. doi: 10.1006/geno.1998.5458. Genomics. 1998. PMID: 9806841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,077 results

Search Page